2. Gene
  3. PIGS - phosphatidylinositol glycan anchor biosynthesis class S Gene

PIGS - phosphatidylinositol glycan anchor biosynthesis class S Gene

  • 基因
  • 蛋白
  • 疾病
  • 相关产品

中文名称：磷脂酰肌醇聚糖锚生物合成 S 类

种属: Homo sapiens

同用名: DEE95; PIG-S; GPIBD18

基因 ID: 94005 | 基因类型: protein coding

关于 PIGS

Cytogenetic location: 17q11.2 Genomic coordinates (GRCh38): 17:28,553,387-28,571,524 (from NCBI)

This gene has 35 transcripts (splice variants), 196 orthologues and is associated with 2 phenotypes. Ubiquitous expression in fat (RPKM 16.8), kidney (RPKM 16.1) and 25 other tissues.

功能概要

该基因编码一种参与 GPI 锚生物合成的蛋白质。糖基磷脂酰肌醇 (GPI) 锚是一种在许多血细胞上发现的糖脂，用于将蛋白质锚定到细胞表面。该基因编码多亚基酶 GPI 转酰胺酶的重要组成部分。 GPI 转酰胺酶通过催化完全组装的 GPI 单位向蛋白质的转移，介导 GPI 在内质网中的锚定。[RefSeq 提供，2008 年 7 月]

This gene encodes a protein that is involved in GPI-anchor biosynthesis. The glycosylphosphatidylinositol (GPI) anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene encodes an essential component of the multisubunit Enzyme, GPI transamidase. GPI transamidase mediates GPI anchoring in the endoplasmic reticulum, by catalyzing the transfer of fully assembled GPI units to proteins. [provided by RefSeq, Jul 2008]

PIGS 基因产物(1)

mRNA Protein Name
NM_033198.4 NP_149975.1 GPI transamidase component PIG-S

PIGS 蛋白结构

PIG-S

PIG-S: Phosphatidylinositol-glycan biosynthesis class S protein (21 - 550)

  • 0
  • 100
  • 200
  • 300
  • 400
  • 500
  • 555 a.a.
蛋白主名 其他名称

GPI transamidase component PIG-S

GPI transamidase subunit

PIGS 蛋白互作信息

分类
蛋白名称 蛋白编号 互作蛋白 互作蛋白种属 互作蛋白编号 实验方法 参考文献
Intra PIGS Q96S52 KRT40 Homo sapiens Q6A162
Validated Y2H
25416956
Intra PIGS Q96S52 KRTAP10-9 Homo sapiens P60411
Y2H Array
32296183
Intra PIGS Q96S52 KRTAP10-9 Homo sapiens P60411
Y2H Prey Pooling
32296183
Intra PIGS Q96S52 KRTAP9-2 Homo sapiens Q9BYQ4
Validated Y2H
32296183
Intra PIGS Q96S52 KRTAP9-2 Homo sapiens Q9BYQ4
Y2H Array
32296183
Intra PIGS Q96S52 KRTAP9-2 Homo sapiens Q9BYQ4
Y2H Prey Pooling
32296183
Intra PIGS Q96S52 KRTAP1-3 Homo sapiens Q8IUG1
Y2H Prey Pooling
32296183
Intra PIGS Q96S52 KRTAP1-3 Homo sapiens Q8IUG1
Y2H Array
32296183
Intra PIGS Q96S52 KRTAP19-2 Homo sapiens Q3LHN2
Y2H Prey Pooling
32296183
Intra PIGS Q96S52 KRTAP19-2 Homo sapiens Q3LHN2
Y2H Array
32296183
Intra PIGS Q96S52 KRTAP2-4 Homo sapiens Q9BYR9
Y2H Array
32296183
Intra PIGS Q96S52 KRTAP2-4 Homo sapiens Q9BYR9
Y2H Prey Pooling
32296183
Intra PIGS Q96S52 KRTAP2-4 Homo sapiens Q9BYR9
Validated Y2H
32296183
Intra PIGS Q96S52 NOTCH2NLC Homo sapiens P0DPK4
Y2H Array
32296183
Intra PIGS Q96S52 NOTCH2NLC Homo sapiens P0DPK4
Y2H Prey Pooling
32296183
Intra PIGS Q96S52 KRTAP6-3 Homo sapiens Q3LI67
Y2H Prey Pooling
32296183
Intra PIGS Q96S52 KRTAP6-3 Homo sapiens Q3LI67
Y2H Array
32296183
Intra PIGS Q96S52 PIGT Homo sapiens Q969N2
Anti Tag CoIP
12802054
Intra PIGS Q96S52 PIGT Homo sapiens Q969N2
Anti Tag CoIP
11483512
Intra PIGS Q96S52 TRIP6 Homo sapiens Q15654
Y2H Prey Pooling
32296183
Intra PIGS Q96S52 TRIP6 Homo sapiens Q15654
Y2H Array
32296183
Intra PIGS Q96S52 NOTCH2NLA Homo sapiens Q7Z3S9
Y2H Array
25416956
种属间: 跨种属相互作用 种属内: 同种属相互作用

关联疾病

疾病名称 别名
Developmental And Epileptic Encephalopathy 95

Glycosylphosphatidylinositol Biosynthesis Defect 18

GPIBD18

DEE95
Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome 4

MCAHS4

Glycosylphosphatidylinositol Biosynthesis Defect 19

Gpibd19

Developmental And Epileptic Encephalopathy 77

Epileptic Encephalopathy, Early Infantile, 77

Dee77

Eiee77

Developmental And Epileptic Encephalopathy, 77

Early Infantile Epileptic Encephalopathy 77

Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome-4
Developmental And Epileptic Encephalopathy 55

DEE55

Glycosylphosphatidylinositol Biosynthesis Defect 14

Gpibd14

Epileptic Encephalopathy, Early Infantile, 55

Eiee55

Developmental And Epileptic Encephalopathy, 55

Early Infantile Epileptic Encephalopathy 55

Encephalopathy, Epileptic, Early Infantile, Type 55
Developmental And Epileptic Encephalopathy 80

DEE80

Glycosylphosphatidylinositol Biosynthesis Defect 20

Gpibd20

Epileptic Encephalopathy, Early Infantile, 80

Eiee80

Developmental And Epileptic Encephalopathy, 80

Early Infantile Epileptic Encephalopathy 80
Early Infantile Epileptic Encephalopathy

Early Infantile Epileptic Encephalopathy With Burst-Suppression

Early Infantile Epileptic Encephalopathy With Suppression Bursts

Eiee

Early Infantile Epileptic Encephalopathy With Suppression-Bursts

Ohtahara Syndrome

Encephalopathy, Epileptic, Early Infantile
疾病名称 别名
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

相关产品

Approval
生物活性分子 (20)
目录号 产品名 作用方式
纯度 是否罕见病
HY-17498 Atenolol Antagonist 99.94% 是
HY-121383 Labetalol Antagonist 99.88% 否
HY-B0519A Tylosin Inhibitor 99.81% 否
HY-17403 Manidipine dihydrochloride Inhibitor 99.91% 否
HY-70050C Alosetron Hydrochloride Antagonist 99.76% 否
HY-B0273 Sulfadiazine Inhibitor 99.93% 是
HY-B0595 Ramosetron Hydrochloride Antagonist 99.96% 否
HY-134004 Pentoxyverine 98.91% 否
HY-B1055 Pentoxyverine citrate 99.63% 否
HY-P0004 Lysipressin Activator 98.02% 否
HY-B1404 Nylidrin hydrochloride 99.89% 否
HY-P0004A Lysipressin acetate Activator 99.84% 否
HY-B0273A Sulfadiazine sodium Inhibitor ≥98.0% 是
HY-101810 Tazanolast 99.50% 否
HY-70050A Alosetron Antagonist / 否
HY-121166 Levobetaxolol Antagonist / 否
HY-17498R Atenolol (Standard) Antagonist 99.94% 否
HY-70050CR Alosetron Hydrochloride (Standard) Antagonist / 否
HY-70050 Alosetron (Hydrochloride(1:X)) Antagonist / 否
HY-70050B Alosetron ((Z)-2-butenedioate) Antagonist / 否
Clinical Phase
生物活性分子 (19)
目录号 产品名 作用方式
纯度 Phase
HY-13402 Varespladib Inhibitor 99.94% Phase 3
HY-18600A Azimilide dihydrochloride Inhibitor 98.91% Phase 3
HY-107384 Asimadoline Agonist 99.36% Phase 3
HY-18600 Azimilide Inhibitor 99.01% Phase 3
HY-13510 Cutamesine dihydrochloride Agonist 98.01% Phase 2
HY-18099A S1RA hydrochloride Antagonist 99.94% Phase 2
HY-18099 S1RA Antagonist 99.43% Phase 2
HY-156684 GDC-6599 Inhibitor 99.77% Phase 2
HY-121156 Anatibant Antagonist / Phase 2
HY-117283 rel-Aprikalim / Phase 2
HY-16765 Axelopran Antagonist / Phase 2
HY-19249 Z-335 sodium Antagonist / Phase 2
HY-114724 HSR-609 / Phase 2
HY-115831 SAR247799 Agonist 97.21% Phase 1
HY-139589 Zaloglanstat Inhibitor 98.50% Phase 1
HY-13438 AZD3839 free base Inhibitor 99.91% Phase 1
HY-115877 GDC-0334 Antagonist / Phase 1
HY-19109 RG-7152 / Phase 1
HY-19261 T-0632 Inhibitor / Phase 1
Pre-clinical Phase
生物活性分子 (269)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-50202 Etomoxir Inducer 99.92% 是
HY-P2974 Elastase, Porcine pancreas / 否
HY-50202A Etomoxir sodium salt Inducer 99.73% 是
HY-19989A MK-571 sodium 99.24% 否
HY-P1635 Pepsin / 否
HY-15754 CGP37157 Inhibitor 99.50% 否
HY-B2060A Tiamulin fumarate Inhibitor ≥98.0% 否
HY-100001 SKF-96365 hydrochloride 99.91% 否
HY-111925 BI-749327 Antagonist 99.91% 否
HY-103447 Zearalenone Activator 98.50% 否
HY-106301 Devazepide Antagonist 99.58% 否
HY-121238 Hyocholic Acid 99.46% 否
HY-101044 PPADS tetrasodium ≥95.0% 否
HY-P2831 Esterase, pig liver / 否
HY-19989 MK-571 98.56% 否
HY-106840 L-365260 Antagonist 99.93% 否
HY-106369 HMR 1556 Inhibitor 99.90% 否
HY-108511 PB28 dihydrochloride 99.97% 否
HY-15039 SSR240612 Antagonist 99.51% 否
HY-13283 MF63 Inhibitor 99.55% 否
HY-135976 P2X3 antagonist 34 Antagonist 99.71% 否
HY-103197 2-Methoxyidazoxan monohydrochloride Antagonist 98.64% 否
HY-108591 L-364,373 Activator 99.67% 否
HY-B2060 Tiamulin Inhibitor 98.07% 否
HY-101396 ICA-069673 Activator 99.65% 否
HY-12887 Piclamilast Inhibitor 99.74% 否
HY-15744 LY255283 Antagonist 98.52% 否
HY-101232 Tiotidine Antagonist 99.28% 否
HY-12709A ARC 239 dihydrochloride Antagonist 99.57% 否
HY-128965 N-Glycolylneuraminic acid 99.90% 否
HY-150270A NP-1815-PX sodium Antagonist 99.62% 否
HY-106961 ONO 1301 Agonist 99.06% 否
HY-16915 RPR-260243 Activator 99.91% 否
HY-101222 SB-203186 hydrochloride Antagonist 99.94% 否
HY-101341 RS 67333 hydrochloride Agonist 99.73% 否
HY-101408 Docosatrienoic Acid ≥99.0% 否
HY-B1340 Carbadox Inhibitor ≥98.0% 否
HY-P1096 A71623 Agonist 99.90% 否
HY-14336A SB 271046 Hydrochloride Antagonist 99.93% 否
HY-17498S Atenolol-d7 Antagonist 96.67% 否
HY-103447R Zearalenone (Standard) Activator 98.85% 否
HY-108594 PD-118057 Activator ≥99.0% 否
HY-121799A Taurohyocholic acid sodium salt 96.80% 否
HY-124959 Spiradoline mesylate Agonist 99.95% 否
HY-135108 QWF Peptide Antagonist 98.10% 否
HY-N10549 Gigantol 99.79% 否
HY-P2317 Cecropin P1, porcine Inhibitor 99.83% 否
HY-106840A L-365260 hemihydrate Antagonist 99.75% 否
HY-134116 Isoflupredone acetate 98.55% 否
HY-50723 3-Methylxanthine 99.62% 否
HY-B1241 Dihydrostreptomycin sulfate Inhibitor ≥98.0% 否
HY-E70198 Pepsin (MS Grade) / 否
HY-N0757 8-​O-​Acetylharpagide Inhibitor 99.75% 否
HY-P0263A Dermaseptin TFA Inhibitor 99.21% 否
HY-P1494 Substance P (1-9) 98.47% 否
HY-D2337 Quinophthalone / 否
HY-13402A Varespladib sodium Inhibitor ≥98.0% 是
HY-101390 (+)-Niguldipine hydrochloride Antagonist 98.06% 否
HY-101676 RG-12525 98.31% 否
HY-103149 SB-216641A Antagonist ≥98.0% 否
HY-107384A Asimadoline hydrochloride Agonist 99.82% 否
HY-107566 Conessine ≥98.0% 否
HY-123801 MIDD0301 Modulator 98.14% 否
HY-B2162C Chondroitin sulfate (from pig) 95.06% 否
HY-N8276 Ro 3-1314 Inhibitor ≥99.0% 否
HY-P1256C JMV 449 acetate Agonist 99.84% 否
HY-Y0032 Thiosemicarbazide Inhibitor ≥98.0% 否
HY-B0519B Tylosin phosphate Inhibitor 98.08% 否
HY-B1136 Menbutone 99.94% 否
HY-N2106 Dehydroevodiamine Inhibitor 99.93% 否
HY-100164 SDZ-MKS 492 Inhibitor 99.77% 否
HY-101231 ICI-204448 98.68% 否
HY-101343 RS 39604 Antagonist ≥98.0% 否
HY-103089 LY393558 Antagonist ≥99.0% 否
HY-103158 BW B70C Inhibitor / 否
HY-103447S1 Zearalenone-13C18 98.7% 否
HY-107610 SR2640 hydrochloride Antagonist 99.60% 否
HY-107647A (R)-(+)-Dimethindene maleate Antagonist 99.94% 否
HY-114164C Thrombin, Pig blood Activator / 否
HY-121156A Anatibant hydrochloride Antagonist / 否
HY-121495 BKI-1369 Inhibitor 98.77% 否
HY-13213 AM211 Antagonist 98.79% 否
HY-148144A Clobutinol hydrochloride Inhibitor 99.22% 否
HY-50723R 3-Methylxanthine (Standard) / 否
HY-50723S 3-Methylxanthine-13C4,15N3 / 否
HY-E70231 Defibrase, deinagkistrodonacutus / 否
HY-P2289A β-defesin 1 (pig) (TFA) Inhibitor 99.11% 否
HY-105872 Trifenagrel 99.35% 否
HY-19102 NSP-805 Inhibitor 99.28% 否
HY-N10620 Melitidin 98.03% 否
HY-151198 CHF-6366 / 否
HY-B0519AS Tylosin-d3 Inhibitor / 否
HY-100481 RP 72540 Antagonist / 否
HY-100724 YM-17690 Agonist / 否
HY-101208 L694247 Agonist / 否
HY-101225 8 Hydroxy PIPAT oxalate / 否
HY-101236 ICI 192605 Antagonist / 否
HY-101590A Symetine dihydrochloride Inhibitor / 否
HY-103143A SDZ 205-557 Antagonist / 否
HY-103296 Bombinakinin M Agonist / 否
HY-103304 CGRP antagonist 4 / 否
HY-103447S (Rac)-Zearalenone-d6 / 否
HY-105215 FK888 Antagonist / 否
HY-105572 Moveltipril calcium / 否
HY-106076 REV 2871 Inhibitor / 否
HY-106150 Eniporide / 否
HY-106756 Spiradoline Agonist / 否
HY-106831 R 56865 / 否
HY-106961A (Z)-ONO 1301 / 否
HY-107563 ROS 234 Antagonist / 否
HY-107563A ROS 234 dioxalate Antagonist / 否
HY-107611 Ro 24-5913 Antagonist / 否
HY-107644 AQ-RA 741 Antagonist / 否
HY-108511A PB28 / 否
HY-108561 L-670596 Antagonist / 否
HY-111918 A71378 Agonist / 否
HY-112739 SC-41930 Agonist / 否
HY-112742 CP-195543 Antagonist / 否
HY-113465A 11-trans Leukotriene E4 / 否
HY-113693 ONO-RS-347 / 否
HY-113695 BW A575C Inhibitor / 否
HY-113758 LY 163443 Antagonist / 否
HY-113781 Ractopamine Agonist / 否
HY-113829 Valnemulin Inhibitor / 否
HY-114538 Asobamast / 否
HY-114751 16,16-Dimethylprostaglandin E1 / 否
HY-114792 15-Methylprostaglandin E1 / 否
HY-114920 Piprofurol Inhibitor / 否
HY-116033 BMS-363131 Inhibitor / 否
HY-116042 FSCPX Antagonist 99.72% 否
HY-116051 16,16-Dimethylprostaglandin F2α / 否
HY-116591 8-Iso-15-keto prostaglandin F2β / 否
HY-116638 AHR-5333 Inhibitor / 否
HY-116638A AHR-5333 (mandelate) Inhibitor / 否
HY-117811 (R,R)-MK 287 / 否
HY-117842 KY 234 Inhibitor / 否
HY-117896 SC-50605 Antagonist / 否
HY-117952 L 743310 Antagonist / 否
HY-118033 SQ 30774 Inhibitor / 否
HY-118185 SQ 31844 / 否
HY-118220 EP 171 Agonist / 否
HY-118463 Benzomalvin A / 否
HY-118546 JNJ-17156516 Antagonist / 否
HY-120302 PD 140376 Antagonist / 否
HY-120355 AP14145 Inhibitor / 否
HY-121183 Aprikalim Activator / 否
HY-121520 Docosahexaenoyl glycine Activator / 否
HY-121621 RO5101576 / 否
HY-122331 Norbormide Inhibitor 98.91% 否
HY-122409 Cularine / 否
HY-123189 LY 171859 / 否
HY-123206 R-96544 free base Antagonist / 否
HY-126569 Efrotomycin Inhibitor / 否
HY-128043 11-Deoxy prostaglandin E1 / 否
HY-128965R N-Glycolylneuraminic acid (Standard) / 否
HY-129101 (-)-Eseroline fumarate Antagonist / 否
HY-130138B (5S,6R)-DiHETEs / 否
HY-131605 Ganciclovir triphosphate / 否
HY-131696 11-deoxy Prostaglandin F1α / 否
HY-13511AS Rupatadine-d4 fumarate / 否
HY-136634 BTM-1042 / 否
HY-136677 Lnd 796 / 否
HY-139112 Leukotriene B4 dimethyl amide / 否
HY-14297 Milveterol / 否
HY-147014 Cyclic HPMPC Inhibitor / 否
HY-148038 5-HT3 antagonist 5 Antagonist 99.75% 否
HY-148144 Clobutinol Inhibitor / 否
HY-14939A Vapitadine hydrochloride Antagonist / 否
HY-149942 PAP-IN-1 / 否
HY-150270 NP-1815-PX Antagonist / 否
HY-157796 β2AR agonist 4 Agonist / 否
HY-15791 FR173657 Antagonist / 否
HY-160932 RS-15385-198 Antagonist / 否
HY-163702 CHF-6550 / 否
HY-164010 SUN-1334H free base Inhibitor / 否
HY-164650 Pirodomast Inhibitor / 否
HY-16765A Axelopran sulfate Antagonist / 否
HY-17498B Atenolol hydrochloride Antagonist / 否
HY-18600AS Azimilide-d8 dihydrochloride Inhibitor / 否
HY-19042 YM-16638 Antagonist / 否
HY-19443 UCB-35440 / 否
HY-A0168S Regadenoson-d3 Agonist / 否
HY-B0204B (-)-Pimobendan / 否
HY-B1340S Carbadox-d3 Inhibitor / 否
HY-E70197 Calpain-1 (pig) / 否
HY-E70437 Guinea pig liver transglutaminase / 否
HY-N12520 Helveticoside / 否
HY-N3931 Gardneramine / 否
HY-N8671 Withanoside V / 否
HY-NP015 SLT/SLT-IIe (O139) protein Inducer / 否
HY-P10006 Leumorphin, human Agonist / 否
HY-P1016 BQ-3020 Antagonist / 否
HY-P1016B BQ-3020 ammonium Agonist 99.18% 否
HY-P10291 [Pro34]Neuropeptide Y, porcine Agonist / 否
HY-P10599 Scyliorhinin I Agonist / 否
HY-P1112 Sarafotoxin S6a Agonist / 否
HY-P1112A Sarafotoxin S6a TFA Agonist / 否
HY-P1256 JMV 449 Agonist / 否
HY-P2289 β-defesin 1 (pig) Inhibitor / 否
HY-P2291 Beta-defensin 103 isoform X1, pig Inhibitor / 否
HY-P2291A Beta-defensin 103 isoform X1, pig TFA Inhibitor / 否
HY-P2317A Cecropin P1, porcine acetate Inhibitor / 否
HY-P2703 Peptide YY (pig) Activator / 否
HY-P2747 Aconitate hydratase, pig heart / 否
HY-P2807J L-Lactate Dehydrogenase (L-LDH), pig muscle / 否
HY-P3057 [D-Trp11]-Neurotensin Modulator / 否
HY-P3563 [Lys4] Sarafotoxin S6c Agonist / 否
HY-P4841 GLP-1 (7-36)-Lys(biotinyl) amide (human, bovine, guinea pig, mouse, rat) / 否
HY-RS10501 PIGS Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-W127485 cis-9,10-Methyleneoctadecanoic Acid / 否
HY-101167 Aminopotentidine Antagonist / 否
HY-101390A (-)-Niguldipine hydrochloride Antagonist / 否
HY-101724 ReN-1869 hydrochloride Antagonist / 否
HY-101749 WAY127093B racemate Inhibitor / 否
HY-103143 SDZ 205-557 hydrochloride Antagonist / 否
HY-106049 Acrihellin / 否
HY-106514 Prifelone Inhibitor / 否
HY-106899A (rel)-MK 287 / 否
HY-107564 Impentamine dihydrobromide / 否
HY-107566A Conessine dihydrobromide / 否
HY-109023 Azeloprazole / 否
HY-114723 NPD9948 / 否
HY-114743 GS 283 / 否
HY-115381 Lipoxin A5 / 否
HY-116400 BN 50341 / 否
HY-116606 LY108742 Antagonist / 否
HY-116680 LY53857 Antagonist / 否
HY-117255 ZM260384 / 否
HY-117557 LY306669 Antagonist / 否
HY-117706 LY 292728 Antagonist / 否
HY-117717 (Rac)-SC-31391 Activator / 否
HY-117862 TASP0412098 / 否
HY-118350 FR 75513 / 否
HY-118378 ZD6021 Antagonist / 否
HY-118444 (Rac)-WRC-0571 Antagonist / 否
HY-119883 A-61603 (free base） Agonist / 否
HY-119908 Hetramine / 否
HY-120418 L-687306 / 否
HY-120476 JNJ-39729209 Inhibitor / 否
HY-120688 L-772405 Agonist / 否
HY-120955 (+)-5-trans Cloprostenol / 否
HY-121007 Bepafant / 否
HY-121763 SCH-43478 Inhibitor / 否
HY-123459 Garomefrine (hydrochlorid) / 否
HY-123596 LAS191859 Antagonist / 否
HY-126063 ICI-204448 free acid / 否
HY-126862 AQ-RA 721 / 否
HY-129785 CP-220629 Inhibitor / 否
HY-130138A (5S,6R)-DiHETE / 否
HY-13213A AM211 sodium Antagonist / 否
HY-137325A 2-Chloro-ATP sodium / 否
HY-138110 Toladryl Antagonist / 否
HY-149589 11(Z),14(Z)-Eicosadienoic acid Inhibitor / 否
HY-156978 Ritolukast Antagonist / 否
HY-15718B Istaroxime oxalate Inhibitor / 否
HY-165524 AM 92016 Inhibitor / 否
HY-167689 Parethoxycaine hydrochloride / 否
HY-167902 YM-31636 free base Agonist / 否
HY-19633A CS-003 / 否
HY-50723S1 3-Methylxanthine-d3 / 否
HY-D0808 Meldola blue / 否
HY-N3136 Onitin Antagonist / 否
HY-N3167 Nyasicoside / 否
HY-P2015A Berlopentin hydrochloride / 否
HY-W420033 (S)-(+)-Etomoxir / 否
HY-W754020 Elbanizine Inhibitor / 否
HY-113442A 6-trans-Leukotriene B4 / 否
HY-100254 TAK-024 Inhibitor / 否
HY-107018 AR-A 2 Antagonist / 否
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z